Recent trends in osteoporosis treatment after hip fracture: Improving but wholly inadequate

Journal of Rheumatology

Volumn 35, Issue 2, 2008, Pages 190-192

  Majumdar, Sumit R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; RALOXIFENE; ZOLEDRONIC ACID;

BONE MASS; CLINICAL PRACTICE; EDITORIAL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH STATUS; HIP FRACTURE; HUMAN; MORTALITY; OSTEOPOROSIS; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL;

BONE DENSITY CONSERVATION AGENTS; EVIDENCE-BASED MEDICINE; HIP FRACTURES; HUMANS; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 39549123038     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465-75.
2. Colon-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to risk of subsequent fracture: data from two longitudinal studies. Osteoporos Int 2003;14:879-83.
3. Berry SD, Samelson EJ, Hannan MT, et al. Second hip fracture in older men and women. Arch Intern Med 2007;167:1971-6.
4. Majumdar SR, Beaupre LA, Harley CH, et al. Use of a case-manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 2007;167:2110-5.
5. Cadarette S, Katz J, Brookhart MA, et al. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol 2008;35:319-26
6. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34.
7. Sedlak CA, Doheny MO, Estok PJ. Osteoporosis in older men: knowledge and health beliefs. Orthopedic Nursing 2000;19:38-42.
8. Majumdar SR, Elmasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 2004;292:1983-8.
9. Kaufman JD, Bolander ME, Bunta AD, et al. Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 2003;85:1837-42.
10. Gardner MJ, Brophy RJ, Demetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture: a prospective randomized trial. J Bone Joint Surg Am 2005;87:3-7.
11. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zolendronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-809.